{"summary": "persons who develop severe acute lower respiratory illness within 14 days after traveling from the Arabian Peninsula or neighboring countries may be considered for evaluation for MERS-CoV. if no obvious etiology is identified, local public health officials be notified and testing for MERS-CoV conducted, if indicated. no FDA-approved tests that identify MERS-CoV in clinical specimens. this assay will be deployed to laboratory response network (LRN) laboratories in all 50 states."}